Helius Operating Margin from 2010 to 2025
| HSDT Stock | USD 0.41 0.01 2.50% |
Check Helius Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Helius Medical's main balance sheet or income statement drivers, such as Interest Expense of 280.8 K, Selling General Administrative of 9.6 M or Other Operating Expenses of 16.1 M, as well as many indicators such as Price To Sales Ratio of 33.18, Dividend Yield of 0.0 or PTB Ratio of 18.01. Helius financial statements analysis is a perfect complement when working with Helius Medical Valuation or Volatility modules.
Helius | Operating Margin |
Latest Helius Medical's Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of Helius Medical Technologies over the last few years. It is Helius Medical's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Helius Medical's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (79.80) % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
Helius Operating Margin Regression Statistics
| Arithmetic Mean | (41.73) | |
| Geometric Mean | 37.79 | |
| Coefficient Of Variation | (40.73) | |
| Mean Deviation | 15.84 | |
| Median | (55.81) | |
| Standard Deviation | 17.00 | |
| Sample Variance | 288.86 | |
| Range | 39.7653 | |
| R-Value | 0.81 | |
| Mean Square Error | 106.52 | |
| R-Squared | 0.66 | |
| Significance | 0.0001 | |
| Slope | 2.89 | |
| Total Sum of Squares | 4,333 |
Helius Operating Margin History
About Helius Medical Financial Statements
Helius Medical shareholders use historical fundamental indicators, such as Operating Margin, to determine how well the company is positioned to perform in the future. Although Helius Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Helius Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Helius Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator , is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. Helius Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 19 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Helius Stock Analysis
When running Helius Medical's price analysis, check to measure Helius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Helius Medical is operating at the current time. Most of Helius Medical's value examination focuses on studying past and present price action to predict the probability of Helius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Helius Medical's price. Additionally, you may evaluate how the addition of Helius Medical to your portfolios can decrease your overall portfolio volatility.